“…Even cells derived from tumors, in most cases, exhibit such a pattern of limited division and proliferation. The SV40 early genes have been introduced into a wide range of cells, and the induced phenotypes have been extensively studied ( [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20], human cells reviewed in [21,22]), showing that these cells may retain some of their initial characteristics of differentiated state, including responses to inducers: angiotensin-converting enzyme was occasionally detectable in transformed endothelial cells [6], Schwann cell lines synthesised specific proteins [16], major keratins in transformed epidermal cells were similar to those found in their normal counterparts [17], bronchial epithelial cells retained the ability to undergo squamous diffel'entiation when exposed to TPA or TGF-~ [15], transformed vascular smooth muscle cells had normal dose-* In memoriam to Daniel Sandoz ** Correspondence and reprints response curves to heparin [19], breast epithelial cell lines can differentiate along the myo-epithelial-like cell pathway [20], embryonal cells may still be induced to differentiate with retinoic acid [13]. The maintenance of the immortalized phenotype is dependent on the presence of the large T protein [2], involving gene activation of transcription factors, ie stimulating Ha-ras and trans-acting factor Spl at the mRNA level and affecting the transcription factor PEAl, and also involving protein-protein interaction with "anti-oncogene products" such as p53, pll0 Rb and p120, and with enhancer-binding proteins such as AP2 (reviewed in [3][4][5]).…”